wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38692308-93B552B4-155C-425D-BD8A-A24E0022A96D
Q38692308-93B552B4-155C-425D-BD8A-A24E0022A96D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38692308-93B552B4-155C-425D-BD8A-A24E0022A96D
Poly(adenosine diphosphate-ribose) polymerase as therapeutic target: lessons learned from its inhibitors.
P2860
Q38692308-93B552B4-155C-425D-BD8A-A24E0022A96D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38692308-93B552B4-155C-425D-BD8A-A24E0022A96D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3945253b63ec2044a0d225c82db9a95d6ea6c1c0
P2860
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer